This comprehensive screening study corroborates that the risk of PPS maculopathy is primarily driven by cumulative PPS exposure but also suggests a possible role for other factors including age, gender, and body weight. These findings have global public safety implications and may help inform dosing guidelines and screening protocols.
Shiromani et al. (Tue,) studied this question.